CA2374820A1 - Inhibiteurs du facteur xa - Google Patents
Inhibiteurs du facteur xa Download PDFInfo
- Publication number
- CA2374820A1 CA2374820A1 CA002374820A CA2374820A CA2374820A1 CA 2374820 A1 CA2374820 A1 CA 2374820A1 CA 002374820 A CA002374820 A CA 002374820A CA 2374820 A CA2374820 A CA 2374820A CA 2374820 A1 CA2374820 A1 CA 2374820A1
- Authority
- CA
- Canada
- Prior art keywords
- group
- 4alkyl
- phenyl
- member selected
- ring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
- C07C311/46—Y being a hydrogen or a carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C317/32—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/10—Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Furan Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
L'invention concerne des composés représentés par la formule générale A-Y-D-E-G-J-Z-L, dans laquelle A-Y-D-E-G-J-Z et L sont tels que définis dans l'invention. Ces composés sont actifs contre le facteur Xa mammalien. Ils sont utilisés <i>in vitro</i> et <i>in vivo</i> pour prévenir ou traiter les troubles de la coagulation.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13581999P | 1999-05-24 | 1999-05-24 | |
US60/135,819 | 1999-05-24 | ||
PCT/US2000/014207 WO2000071512A1 (fr) | 1999-05-24 | 2000-05-24 | Inhibiteurs du facteur xa |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2374820A1 true CA2374820A1 (fr) | 2000-11-30 |
Family
ID=22469841
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002374820A Abandoned CA2374820A1 (fr) | 1999-05-24 | 2000-05-24 | Inhibiteurs du facteur xa |
CA002382751A Abandoned CA2382751A1 (fr) | 1999-05-24 | 2000-05-24 | Inhibiteurs du facteur xa |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002382751A Abandoned CA2382751A1 (fr) | 1999-05-24 | 2000-05-24 | Inhibiteurs du facteur xa |
Country Status (5)
Country | Link |
---|---|
EP (2) | EP1189879A1 (fr) |
JP (2) | JP2003500387A (fr) |
AU (2) | AU5158100A (fr) |
CA (2) | CA2374820A1 (fr) |
WO (2) | WO2000071509A1 (fr) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2324153A1 (fr) | 1998-03-19 | 1999-09-23 | Ajinomoto Co., Inc. | Derives d'aminoisoquinoleine |
DE10008329A1 (de) * | 2000-02-23 | 2001-08-30 | Merck Patent Gmbh | Aminosulfonylbiphenylderivate |
DE10014645A1 (de) | 2000-03-24 | 2001-09-27 | Merck Patent Gmbh | Substituierte Biphenylderivate |
DE10037146A1 (de) * | 2000-07-29 | 2002-02-07 | Merck Patent Gmbh | Acetamidderivate |
DE10046272A1 (de) * | 2000-09-19 | 2002-03-28 | Merck Patent Gmbh | Aminoheterocyclen (Faktor Xa Inhibitoren 14) |
DE10117823A1 (de) * | 2001-04-10 | 2002-10-17 | Merck Patent Gmbh | Oxalsäurederivate |
DE10124867A1 (de) * | 2001-05-22 | 2002-11-28 | Boehringer Ingelheim Pharma | Substituierte Aryl- und Heteroarylderivate, deren Herstellung und deren Verwendung als Arzneimittel |
US7005437B2 (en) | 2001-05-22 | 2006-02-28 | Boehringer Ingelheim Pharma Kg | Substituted aryl and heteroaryl derivatives, the preparation thereof and the use therof as pharmaceutical compositions |
DE10139060A1 (de) | 2001-08-08 | 2003-02-20 | Merck Patent Gmbh | Phenylderivate |
AR037097A1 (es) | 2001-10-05 | 2004-10-20 | Novartis Ag | Compuestos acilsulfonamidas, composiciones farmaceuticas y el uso de dichos compuestos para la preparacion de un medicamento |
GB0124933D0 (en) | 2001-10-17 | 2001-12-05 | Glaxo Group Ltd | Chemical compounds |
GB0124939D0 (en) | 2001-10-17 | 2001-12-05 | Glaxo Group Ltd | Chemical compounds |
GB0124941D0 (en) | 2001-10-17 | 2001-12-05 | Glaxo Group Ltd | Chemical compounds |
GB0124934D0 (en) | 2001-10-17 | 2001-12-05 | Glaxo Group Ltd | Chemical compounds |
PA8557501A1 (es) | 2001-11-12 | 2003-06-30 | Pfizer Prod Inc | Benzamida, heteroarilamida y amidas inversas |
WO2003042190A1 (fr) | 2001-11-12 | 2003-05-22 | Pfizer Products Inc. | Derives de n-adamantylalkyle benzamide en tant qu'antagonistes du recepteur p2x7 |
PT1474395E (pt) | 2002-02-12 | 2008-01-02 | Smithkline Beecham Corp | Derivados de nicotinamida úteis como inibidores de p38 |
DE10214832A1 (de) * | 2002-04-04 | 2003-10-16 | Merck Patent Gmbh | Phenylderivate 4 |
CN100513398C (zh) | 2002-12-03 | 2009-07-15 | Axys药物公司 | 作为因子viia抑制剂的2-(2-羟基联苯-3-基)-1h-苯并咪唑-5-甲脒衍生物 |
PE20040804A1 (es) | 2002-12-19 | 2004-12-31 | Boehringer Ingelheim Pharma | DERIVADOS DE CARBOXAMIDAS COMO INHIBIDORES DEL FACTOR Xa |
PA8591801A1 (es) | 2002-12-31 | 2004-07-26 | Pfizer Prod Inc | Inhibidores benzamidicos del receptor p2x7. |
US7071223B1 (en) | 2002-12-31 | 2006-07-04 | Pfizer, Inc. | Benzamide inhibitors of the P2X7 receptor |
GB0308186D0 (en) | 2003-04-09 | 2003-05-14 | Smithkline Beecham Corp | Novel compounds |
GB0308201D0 (en) | 2003-04-09 | 2003-05-14 | Smithkline Beecham Corp | Novel compounds |
ES2396565T3 (es) | 2003-05-12 | 2013-02-22 | Pah Usa 15 Llc | Inhibidores benzamida del receptor P2X7 |
GB0318814D0 (en) | 2003-08-11 | 2003-09-10 | Smithkline Beecham Corp | Novel compounds |
US7371743B2 (en) | 2004-02-28 | 2008-05-13 | Boehringer Ingelheim International Gmbh | Carboxylic acid amides, the preparation thereof and their use as medicaments |
US7550487B2 (en) * | 2004-03-26 | 2009-06-23 | Hoffmann-La Roche Inc. | Pyrrolidine-3,4-dicarboxamide derivatives |
US7429604B2 (en) | 2004-06-15 | 2008-09-30 | Bristol Myers Squibb Company | Six-membered heterocycles useful as serine protease inhibitors |
AU2005258911A1 (en) | 2004-06-29 | 2006-01-12 | Pfizer Products Inc. | Method for preparing 5-`4-(2-hydroxy-propyl)-3,5-dioxo-4,5-dihydro-3H`1,2,4!triazin-2-YL!-benzamide derivatives by deprotecting the hydroxyl-protected precursers |
WO2006101937A1 (fr) | 2005-03-18 | 2006-09-28 | Janssen Pharmaceutica N.V. | Acylhydrazones en tant que modulateurs de kinase |
WO2008059370A2 (fr) | 2006-11-17 | 2008-05-22 | Pfizer Japan Inc. | Composés bicyclocarboxyamides substitués |
CA2804593C (fr) | 2010-07-09 | 2015-11-24 | Pfizer Limited | Derives de biphenyloxybenzensulphonamide utiles en tant qu'inhibiteurs du canal sodique |
CN104693097A (zh) * | 2015-02-13 | 2015-06-10 | 佛山市赛维斯医药科技有限公司 | 一类含双酰肼和烷氧萘基结构的化合物、制备方法及其用途 |
CN104710341A (zh) * | 2015-02-13 | 2015-06-17 | 佛山市赛维斯医药科技有限公司 | 一类含双酰肼和萘基结构的化合物、制备方法及其用途 |
CN104693096A (zh) * | 2015-02-13 | 2015-06-10 | 佛山市赛维斯医药科技有限公司 | 含双酰肼和萘基结构的化合物、制备方法及其用途 |
CN104693099A (zh) * | 2015-02-13 | 2015-06-10 | 佛山市赛维斯医药科技有限公司 | 一种含双酰肼和萘基结构的化合物及其用途 |
CN104693102A (zh) * | 2015-02-13 | 2015-06-10 | 佛山市赛维斯医药科技有限公司 | 一种双酰肼类化合物、其制备方法及其用途 |
CN104693093A (zh) * | 2015-02-13 | 2015-06-10 | 佛山市赛维斯医药科技有限公司 | 双酰肼类FXa抑制剂、制备方法及其用途 |
CN104693101A (zh) * | 2015-02-13 | 2015-06-10 | 佛山市赛维斯医药科技有限公司 | 一种双酰肼类衍生物、其制备方法及其用途 |
CN104693095A (zh) * | 2015-02-13 | 2015-06-10 | 佛山市赛维斯医药科技有限公司 | 一类双酰肼类FXa抑制剂及其用途 |
CN108976150B (zh) * | 2017-06-05 | 2022-11-18 | 重庆博腾制药科技股份有限公司 | 一种3-乙基-4-氟苯腈的制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0960102A1 (fr) * | 1996-07-08 | 1999-12-01 | Du Pont Pharmaceuticals Company | AMIDINOINDOLES, AMIDINOAZOLES ET LEURS ANALOGUES AGISSANT EN TANT QU'INHIBITEURS DU FACTEUR Xa ET DE LA THROMBINE |
US5886191A (en) * | 1997-08-18 | 1999-03-23 | Dupont Pharmaceuticals Company | Amidinoindoles, amidinoazoles, and analogs thereof |
-
2000
- 2000-05-24 AU AU51581/00A patent/AU5158100A/en not_active Abandoned
- 2000-05-24 JP JP2000619769A patent/JP2003500387A/ja active Pending
- 2000-05-24 CA CA002374820A patent/CA2374820A1/fr not_active Abandoned
- 2000-05-24 WO PCT/US2000/014194 patent/WO2000071509A1/fr not_active Application Discontinuation
- 2000-05-24 EP EP00936235A patent/EP1189879A1/fr not_active Withdrawn
- 2000-05-24 CA CA002382751A patent/CA2382751A1/fr not_active Abandoned
- 2000-05-24 WO PCT/US2000/014207 patent/WO2000071512A1/fr not_active Application Discontinuation
- 2000-05-24 JP JP2000619766A patent/JP2003500384A/ja active Pending
- 2000-05-24 AU AU52837/00A patent/AU5283700A/en not_active Abandoned
- 2000-05-24 EP EP00937699A patent/EP1183234A1/fr not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
JP2003500387A (ja) | 2003-01-07 |
EP1189879A1 (fr) | 2002-03-27 |
WO2000071512A1 (fr) | 2000-11-30 |
AU5283700A (en) | 2000-12-12 |
JP2003500384A (ja) | 2003-01-07 |
WO2000071509A1 (fr) | 2000-11-30 |
AU5158100A (en) | 2000-12-12 |
CA2382751A1 (fr) | 2000-11-30 |
EP1183234A1 (fr) | 2002-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2374820A1 (fr) | Inhibiteurs du facteur xa | |
US6399627B1 (en) | Inhibitors of factor Xa | |
US6632815B2 (en) | Inhibitors of factor Xa | |
US6545055B1 (en) | Inhibitors of factor Xa | |
CA2385592C (fr) | Benzamides et inhibiteurs correspondants du facteur xa | |
US20030114448A1 (en) | Inhibitors of factor Xa | |
US6534535B1 (en) | Inhibitors of factor Xa | |
CA2374947A1 (fr) | Inhibiteurs du facteur xa | |
JP2003509412A (ja) | Xa因子阻害剤 | |
US6686368B1 (en) | Inhibitors of factor Xa | |
CA2371904A1 (fr) | Inhibiteurs du facteur xa | |
US20040082786A1 (en) | Piperazine based inhibitors of factor xa | |
EP1235807A1 (fr) | INHIBITEURS DU FACTEUR Xa A BASE D'ACIDES $g(b)-AMINES, ASPARTIQUES ET DIAMINOPROPIONIQUES | |
WO2002026718A2 (fr) | Inhibiteurs du facteur xa à base de pyrimidine-4-one bicyclique | |
US20040077690A1 (en) | Quaternary amidino based inhibitors of factor xa | |
EP1322643A1 (fr) | Amides piperazine-2-un comme inhibiteurs du facteur xa |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |